Current Urology ReportsPub Date : 2024-08-01Epub Date: 2024-05-26DOI: 10.1007/s11934-024-01207-7
Lan Anh S Galloway, Amy N Luckenbaugh
{"title":"Preparing Trainees to Rebound from Surgical Complications.","authors":"Lan Anh S Galloway, Amy N Luckenbaugh","doi":"10.1007/s11934-024-01207-7","DOIUrl":"10.1007/s11934-024-01207-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>In this review, we aim to summarize the impact of surgical complications and adverse events on surgeons, including psychiatric illnesses. We evaluate current programs to develop trainee well-being and investigate research within the field of urology.</p><p><strong>Recent findings: </strong>Surgical complications and adverse events affect all surgeons, including surgical trainees. Research estimates that 80% of healthcare professionals have been involved in an event that affected them emotionally. These events can affect physicians in many ways, ranging from negatively impacting their quality of life to leading to psychiatric disorders such as acute stress reactions and post-traumatic stress disorder. Unfortunately, there is no standardized preparation to equip trainees to manage and rebound from the profound emotional impact of surgical complications. Data in this realm is insufficient, especially in urology, and we need more research in order to better evaluate emotional implications of complications on trainees and how we can prepare trainees to handle them.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"169-172"},"PeriodicalIF":2.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141154977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-07-01Epub Date: 2024-05-10DOI: 10.1007/s11934-024-01204-w
Campbell Vogt, Neha R Malhotra
{"title":"Fertility Preservation in Children and Adolescents: Where We Are and Where We Are Going.","authors":"Campbell Vogt, Neha R Malhotra","doi":"10.1007/s11934-024-01204-w","DOIUrl":"10.1007/s11934-024-01204-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review will describe current pediatric and adolescent fertility preservation methodologies and the ethical concerns surrounding these procedures, as well as highlight recent research that may pave the way for the development of new fertility preservation options.</p><p><strong>Recent findings: </strong>Research is ongoing to allow prepubertal patients, particularly those with testes, to be able to have biologic children in the future. Studies on sperm in vitro maturation highlight the importance of supporting the spermatogonial stem cell niche for the development of mature sperm. The live birth of a rhesus macaque from in vitro fertilization using prepubertal testicular tissue and in vivo matured sperm gives hope to future human births. For patients with ovaries, prior work has led to successful fertility but further research is underway to refine these techniques and optimize outcomes. Organoid scaffolds have shown promise when being used for in vitro oocyte maturation. For children and adolescents undergoing gonadotoxic treatment, such as chemotherapy, or hormonal treatment, such as gender-affirming hormone therapy, future fertility potential may be negatively impacted. It is recommended that fertility preservation (FP) be offered to these patients and families prior to undergoing treatment. Fertility preservation for postpubertal patients mimics that in adults. For prepubertal children, however, the options are limited and in some cases still experimental. It is essential that this work continues so that we may offer children and adolescents the right to an open future and preserve their fertility potential.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"133-140"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-07-01Epub Date: 2024-05-10DOI: 10.1007/s11934-024-01205-9
Seyed Sajjad Tabei, Wesley Baas, Ayman Mahdy
{"title":"Pharmacotherapy in Stress Urinary Incontinence; A Literature Review.","authors":"Seyed Sajjad Tabei, Wesley Baas, Ayman Mahdy","doi":"10.1007/s11934-024-01205-9","DOIUrl":"10.1007/s11934-024-01205-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>Stress urinary incontinence (SUI) is a commonly observed condition in females, as well as in males who have undergone prostatectomy. Despite the significant progress made in surgical techniques, pharmacotherapy has not yielded substantial outcomes within the clinical domain. This review aims to present a comprehensive overview of the existing pharmacotherapy options for stress urinary incontinence (SUI) and the emerging therapeutic targets in this field.</p><p><strong>Recent findings: </strong>One meta-analysis demonstrated that α-adrenergic medications are more efficacious in improving rather than curing SUI symptoms. One trial showed reduced pad weight gain with PSD-503, a locally administered α-adrenergic receptor agonist. New data show that duloxetine's risk outweighs its benefits. One small-scale trial was found to support the use of locally administered estriol in improving subjective outcomes. Emerging targets include serotonin 5HT<sub>2C</sub> agonists, selective inhibitors of norepinephrine uptake, and myostatin inhibitors. Only one of the evaluated drugs, duloxetine, has been approved by some countries. Currently, trials are evaluating novel targets. Systemic adverse effects such as gastrointestinal upset with duloxetine and orthostatic hypotension with α-adrenoceptor agonists have hampered the efficacy of drugs used to treat SUI in women and men.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"141-148"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-07-01Epub Date: 2024-06-05DOI: 10.1007/s11934-024-01208-6
Kate Dwyer, George E Koch
{"title":"Unlocking Peer Review: Elevating Scholarly Writing and Research Competence in Urology Residency.","authors":"Kate Dwyer, George E Koch","doi":"10.1007/s11934-024-01208-6","DOIUrl":"10.1007/s11934-024-01208-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>It is incumbent upon training programs to set the foundation for evidence-based practices and to create opportunities for trainees to develop into academic leaders. As dedicated resident research time and funding have declined in recent years, residency programs and the field at large will need to create new ways to incorporate scholarly activity into residency curricula.</p><p><strong>Recent findings: </strong>Literature across specialties demonstrates barriers to resident involvement including lack of time, cost, and absent scholarly mentorship. Peer review stands as a ready-made solution that can be formalized into a collaborative relationship with journals. A formal relationship between professional societies, academic journals, and residencies can facilitate the use of peer review as a teaching tool for residency programs.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"163-168"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141247284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-07-01Epub Date: 2024-05-16DOI: 10.1007/s11934-024-01206-8
Francisco E Martins, Nicolaas Lumen, Henriette Veiby Holm
{"title":"Management of the Devastated Bladder Outlet after Prostate CANCER Treatment.","authors":"Francisco E Martins, Nicolaas Lumen, Henriette Veiby Holm","doi":"10.1007/s11934-024-01206-8","DOIUrl":"10.1007/s11934-024-01206-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>Devastating complications of the bladder outlet resulting from prostate cancer treatments are relatively uncommon. However, the combination of the high incidence of prostate cancer and patient longevity after treatment have raised awareness of adverse outcomes deteriorating patients' quality of life. This narrative review discusses the diagnostic work-up and management options for bladder outlet obstruction resulting from prostate cancer treatments, including those that require urinary diversion.</p><p><strong>Recent findings: </strong>The devastated bladder outlet can be a consequence of the treatment of benign conditions, but more frequently from complications of pelvic cancer treatments. Regardless of etiology, the initial treatment ladder involves endoluminal options such as dilation and direct vision internal urethrotomy, with or without intralesional injection of anti-fibrotic agents. If these conservative strategies fail, surgical reconstruction should be considered. Although surgical reconstruction provides the best prospect of durable success, reconstructive procedures are also associated with serious complications. In the worst circumstances, such as prior radiotherapy, failed reconstruction, devastated bladder outlet with end-stage bladders, or patient's severe comorbidities, reconstruction may neither be realistic nor justified. Urinary diversion with or without cystectomy may be the best option for these patients. Thorough patient counseling before treatment selection is of utmost importance. Outcomes and repercussions on quality of life vary extensively with management options. Meticulous preoperative diagnostic evaluation is paramount in selecting the right treatment strategy for each individual patient. The risk of bladder outlet obstruction, and its severest form, devastated bladder outlet, after treatment of prostate cancer is not negligible, especially following radiation. Management includes endoluminal treatment, open or robot-assisted laparoscopic reconstruction, and urinary diversion in the worst circumstances, with varying success rates.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"149-162"},"PeriodicalIF":2.5,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140944496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-06-01Epub Date: 2024-03-22DOI: 10.1007/s11934-024-01201-z
Karen M Doersch, Kathleen A Li, Divya Ajay
{"title":"Flaps and Grafts in Robotic Reconstructive Surgery.","authors":"Karen M Doersch, Kathleen A Li, Divya Ajay","doi":"10.1007/s11934-024-01201-z","DOIUrl":"10.1007/s11934-024-01201-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>The robotic approach is increasingly popular in reconstructive urology. Reconstructive surgeons have commonly used flaps and grafts for obliterating dead space including tissue interposition or as an alternative to mesh in addressing lower urinary tract dysfunction. Advantages of the robotic approach are less incisional pain, excellent visualization in the deep pelvis, and improved surgeon ergonomics. In this literature review, we describe flaps and grafts used in lower urinary tract robotic reconstructive urology, serving as an almanac for these techniques.</p><p><strong>Recent findings: </strong>Omental, peritoneal, vertical rectus abdominis musculocutaneous (VRAM), sigmoid epiploica, gracilis flaps, and Alloderm<sup>™</sup> have been reported for tissue interposition during fistula repair. Fascia lata has been described as a mesh alternative for robotic sacrocolpopexy. Besides providing interposition, flaps support native tissue healing and blood supply. Grafts are easy to use with low patient morbidity, but rely on the blood supply at the recipient site. Robotic reconstruction is an emerging field, and more studies are needed to define the best uses for each flap and graft as well as strategies to maximize outcomes and minimize morbidity.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"109-115"},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-06-01Epub Date: 2024-05-20DOI: 10.1007/s11934-024-01203-x
V Gonzalez de Gor Herrera, J M Asencio Pascual, J González, F Herranz Amo, E LLedó García, A Sánchez Ochoa M, C Hernández Fernández
{"title":"Circumferential Inferior Vena Cavectomy Without Caval Replacement in the Management of Renal Cell Carcinoma with Tumor Thrombus.","authors":"V Gonzalez de Gor Herrera, J M Asencio Pascual, J González, F Herranz Amo, E LLedó García, A Sánchez Ochoa M, C Hernández Fernández","doi":"10.1007/s11934-024-01203-x","DOIUrl":"10.1007/s11934-024-01203-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>Renal cell carcinoma presents a unique proclivity for vascular involvement giving rise to a peculiar form of locally advanced disease so-called tumor thrombus. To date, the only curative strategy for these cases remains surgery, which should aim to remove every vestige of macroscopic disease. Most of the preexisting literature advocates opening the vena cava to allow tumor thrombus removal and subsequent venous suture closure. However, inferior vena cava circumferential resection (cavectomy) without caval replacement is possible in the majority of cases since progressive occlusion facilitates the development of a collateral venous network aimed at maintaining cardiac preload.</p><p><strong>Recent findings: </strong>Radical nephrectomy with tumor thrombectomy remains a surgical challenge not exempt of operative complications even in experienced hands. In opposition to what traditional cavotomy and thrombus withdrawal can offer, circumferential cavectomy without caval replacement would provide comparable or even better oncologic control, decrease the likelihood of operative bleeding, and prevent the development of perioperative pulmonary embolism. This review focuses on the rationale of circumferential IVC resection without caval replacement and the important technical aspects of this approach in cases of renal cell carcinoma with vascular involvement. We also include an initial report on the surgical outcomes of a contemporary series of patients managed under this approach at our center.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"117-124"},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136755/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141064743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-05-01Epub Date: 2024-03-07DOI: 10.1007/s11934-024-01199-4
Vishnuvardhan Ganesan, Deepak Agarwal
{"title":"Medical Advancements in Benign Prostatic Hyperplasia Treatments.","authors":"Vishnuvardhan Ganesan, Deepak Agarwal","doi":"10.1007/s11934-024-01199-4","DOIUrl":"10.1007/s11934-024-01199-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review aims to identify and summarize the current literature on the most recent therapeutic agents and combination strategies for the medical management of lower urinary tract symptoms resulting from benign prostatic hyperplasia.</p><p><strong>Recent findings: </strong>The latest advancements in BPH therapy have been in combination strategies. Alpha blockers continue to be the mainstay of treatment, but research is exploring the synergistic benefits of combining them with 5-alpha reductase inhibitors (5-ARIs), phosphodiesterase-5 (PDE5) inhibitors, and beta-3 agonists. The alpha-blocker + 5-ARI combination remains ideal for enlarged, significantly reducing clinical progression risk compared to monotherapy. Alpha-blocker + PDE5 inhibitor combinations appear safe and potentially beneficial for men with concomitant erectile dysfunction; sildenafil might hold an edge over tadalafil based on limited data. Beta-3 agonists show synergistic effects with alpha blockers for residual storage symptoms, offering similar efficacy to anticholinergics but with a better side effect profile.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"93-98"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140049042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-05-01Epub Date: 2024-02-28DOI: 10.1007/s11934-024-01200-0
Sanjay Sinha
{"title":"The Use of Uroflowmetry as a Diagnostic Test.","authors":"Sanjay Sinha","doi":"10.1007/s11934-024-01200-0","DOIUrl":"10.1007/s11934-024-01200-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>Uroflowmetry is widely used for initial non-invasive evaluation of lower urinary tract disorders. Current clinical use is mostly restricted to a scrutiny of the maximum flow rate and uroflow pattern recorded by a conventional flowmeter in a health care facility. There are several advancements in our understanding and in available technologies that promise to transform clinical utilization of this simple test.</p><p><strong>Recent findings: </strong>Several aspects of the uroflow test in addition to maximum flow rate and uroflow pattern show potential diagnostic utility. This includes flow acceleration, uroflow indices, uroflow-electromyography including lag time, stop uroflow test, and uroflow-based nomograms. There are initial attempts to use artificial intelligence in analysis. There is also new data with regard to factors influencing variability of uroflow testing that might influence the diagnostic value in as yet uncertain ways including diurnal variability, postural variability, locational variability, and operator variability. There are new technologies for uroflow testing in a home environment allowing for easy repetition. However, there are several challenges owing to a paucity of clinical data and standardization. There are also critical lacunae in terminology that need to be addressed. There are exciting new advancements in the field of uroflowmetry. However, there is need to standardize and validate the newer uroflow tracing analyses and technologies.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"99-107"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139982627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Urology ReportsPub Date : 2024-05-01Epub Date: 2024-03-12DOI: 10.1007/s11934-024-01198-5
Timothy W Brandt, Jacqueline M Luizzi, Ronald J Caras
{"title":"Evaluation of Current Surgical BPH Interventions for Young and Elderly Men.","authors":"Timothy W Brandt, Jacqueline M Luizzi, Ronald J Caras","doi":"10.1007/s11934-024-01198-5","DOIUrl":"10.1007/s11934-024-01198-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>Benign prostatic hyperplasia affects the quality of life of a significant number of men, especially as they age. There are continuous innovations in the surgical management of benign prostatic hyperplasia, but many of these innovations are studied in the core population of men 50-70 years of age. This review focuses on the outliers of men aged 18-50 and 70 and older.</p><p><strong>Recent findings: </strong>Older populations have more comorbidities, higher rates of antithrombotic medications, and advanced symptoms. Properly selected older men can safely have significant objective and subjective improvement in their symptoms. The literature was scarce when evaluating younger men; however, ejaculatory preserving techniques are promising providing improvement in symptoms and preserving ejaculation. This review demonstrates that in properly selected elderly patients, improvements in quality of life while also providing safe surgical interventions can be achieved. Ejaculatory preservation techniques demonstrate promising results, but further studies are required to elucidate true outcomes.</p>","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"79-91"},"PeriodicalIF":2.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140109548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}